Merck (US pharmaceutical company)Mòkè默克to announcexuānbù宣布at / for (price)yǐ以$6.7 billion67 yì měiyuán67亿美元to acquireshōugòu收购Terns Pharmaceuticals (biotech company)Terns PharmaceuticalsTerns Pharmaceuticals。
Merck (US pharmaceutical company)
Mòkè
默克
to announce
xuānbù
宣布
at / for (price)
yǐ
以
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
Merck company
Mòkè gōngsī
默克公司
to announce
xuānbù
宣布
at / for (price)
yǐ
以
approximately
yuē
约
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
to obtain / to acquire
huòqǔ
获取
its
qí
其
leukemia
báixuèbìng
白血病
drug candidate
hòuxuǎn yàowù
候选药物
TERN-701 (oral leukemia drug candidate)
TERN-701
TERN-701
this / the current
cǐ cì
此次
merger and acquisition
bìnggòu
并购
aimed at
zhǐzài
旨在
to strengthen / to bolster
qiánghuà
强化
Merck
Mòkè
默克
structural particle
de
的
cancer
áizhèng
癌症
R&D / research and development
yánfā
研发
pipeline (pharmaceutical)
guǎnxiàn
管线
to address / to cope with
yǐ yìngduì
以应对
Keytruda (cancer immunotherapy drug)
Keytruda
Keytruda
patent
zhuānlì
专利
expiry / to expire
dàoqī
到期
structural particle
de
的
pressure / challenge
yālì
压力